Condensed Consolidated Statements of Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Treasury Stock | Warrants | Additional Paid-In- Capital | Accumulated Deficit | Non- Controlling Interest |
Beginning balance (in shares) at Dec. 26, 2021 | | 28,380 | | | | | |
Beginning balance at Dec. 26, 2021 | $ (2,417) | $ 380 | $ (114,577) | $ 2,566 | $ 452,570 | $ (343,261) | $ (95) |
Net income | (7,887) | | | | | (7,913) | 26 |
Shares issued under equity compensation plan (in shares) | | 81 | | | | | |
Shares issued under equity compensation plan | (278) | $ 1 | (279) | | | | |
Distributions to non-controlling interest | (120) | | | | | | (120) |
Stock-based compensation expense | 675 | | | | 675 | | |
Ending balance (in shares) at Mar. 27, 2022 | | 28,461 | | | | | |
Ending balance at Mar. 27, 2022 | (10,027) | $ 381 | (114,856) | 2,566 | 453,245 | (351,174) | (189) |
Beginning balance (in shares) at Dec. 26, 2021 | | 28,380 | | | | | |
Beginning balance at Dec. 26, 2021 | (2,417) | $ 380 | (114,577) | 2,566 | 452,570 | (343,261) | (95) |
Net income | 1,957 | | | | | | |
Ending balance (in shares) at Sep. 25, 2022 | | 28,791 | | | | | |
Ending balance at Sep. 25, 2022 | 909 | $ 384 | (115,331) | 2,566 | 455,012 | (341,571) | (151) |
Beginning balance (in shares) at Mar. 27, 2022 | | 28,461 | | | | | |
Beginning balance at Mar. 27, 2022 | (10,027) | $ 381 | (114,856) | 2,566 | 453,245 | (351,174) | (189) |
Net income | 708 | | | | | 574 | 134 |
Shares issued under equity compensation plan (in shares) | | 235 | | | | | |
Shares issued under equity compensation plan | (326) | $ 2 | (325) | | (3) | | |
Distributions to non-controlling interest | (56) | | | | | | (56) |
Stock-based compensation expense | 820 | | | | 820 | | |
Ending balance (in shares) at Jun. 26, 2022 | | 28,696 | | | | | |
Ending balance at Jun. 26, 2022 | (8,881) | $ 383 | (115,181) | 2,566 | 454,062 | (350,600) | (111) |
Net income | 9,136 | | | | | 9,029 | 107 |
Shares issued under equity compensation plan (in shares) | | 95 | | | | | |
Shares issued under equity compensation plan | (150) | $ 1 | (150) | | (1) | | |
Distributions to non-controlling interest | (147) | | | | | | (147) |
Stock-based compensation expense | 951 | | | | 951 | | |
Ending balance (in shares) at Sep. 25, 2022 | | 28,791 | | | | | |
Ending balance at Sep. 25, 2022 | $ 909 | $ 384 | (115,331) | 2,566 | 455,012 | (341,571) | (151) |
Beginning balance (in shares) at Dec. 25, 2022 | 28,819 | 28,819 | | | | | |
Beginning balance at Dec. 25, 2022 | $ 4,273 | $ 384 | (115,388) | 2,566 | 455,831 | (338,916) | (204) |
Net income | (1,204) | | | | | (1,327) | 123 |
Shares issued under equity compensation plan (in shares) | | 70 | | | | | |
Shares issued under equity compensation plan | (337) | $ 1 | (337) | | (1) | | |
Distributions to non-controlling interest | (152) | | | | | | (152) |
Issuance of common shares and warrants, net of fees (in shares) | | 159 | | | | | |
Proceeds from exercise of warrants | 865 | $ 1 | | (313) | 1,177 | | |
Stock-based compensation expense | 911 | | | | 911 | | |
Ending balance (in shares) at Mar. 26, 2023 | | 29,048 | | | | | |
Ending balance at Mar. 26, 2023 | $ 4,356 | $ 386 | (115,725) | 2,253 | 457,918 | (340,243) | (233) |
Beginning balance (in shares) at Dec. 25, 2022 | 28,819 | 28,819 | | | | | |
Beginning balance at Dec. 25, 2022 | $ 4,273 | $ 384 | (115,388) | 2,566 | 455,831 | (338,916) | (204) |
Net income | $ 2,825 | | | | | | |
Ending balance (in shares) at Sep. 24, 2023 | 29,350 | 29,350 | | | | | |
Ending balance at Sep. 24, 2023 | $ 9,659 | $ 389 | (116,638) | 2,219 | 460,543 | (336,532) | (322) |
Beginning balance (in shares) at Mar. 26, 2023 | | 29,048 | | | | | |
Beginning balance at Mar. 26, 2023 | 4,356 | $ 386 | (115,725) | 2,253 | 457,918 | (340,243) | (233) |
Net income | 2,381 | | | | | 2,216 | 165 |
Shares issued under equity compensation plan (in shares) | | 243 | | | | | |
Shares issued under equity compensation plan | (771) | $ 3 | (772) | | (2) | | |
Distributions to non-controlling interest | (166) | | | | | | (166) |
Issuance of common shares and warrants, net of fees (in shares) | | 18 | | | | | |
Proceeds from exercise of warrants | 96 | | | (34) | 130 | | |
Stock-based compensation expense | 1,305 | | | | 1,305 | | |
Ending balance (in shares) at Jun. 25, 2023 | | 29,309 | | | | | |
Ending balance at Jun. 25, 2023 | 7,201 | $ 389 | (116,497) | 2,219 | 459,351 | (338,027) | (234) |
Net income | 1,649 | | | | | 1,495 | 154 |
Shares issued under equity compensation plan (in shares) | | 41 | | | | | |
Shares issued under equity compensation plan | (141) | $ 0 | (141) | | 0 | | |
Distributions to non-controlling interest | (242) | | | | | | (242) |
Issuance of common shares and warrants, net of fees (in shares) | | 0 | | | | | |
Proceeds from exercise of warrants | 0 | | | 0 | 0 | | |
Stock-based compensation expense | $ 1,192 | | | | 1,192 | | |
Ending balance (in shares) at Sep. 24, 2023 | 29,350 | 29,350 | | | | | |
Ending balance at Sep. 24, 2023 | $ 9,659 | $ 389 | $ (116,638) | $ 2,219 | $ 460,543 | $ (336,532) | $ (322) |